MRI Visual Ratings of Brain Atrophy and White Matter Hyperintensities across the Spectrum of Cognitive Decline Are Differently Affected by Age and Diagnosis

by Hanneke F. M. Rhodius-Meester, Marije R. Benedictus, Mike P. Wattjes, Frederik Barkhof, Frederik Barkhof, Philip Scheltens, Majon Muller, Wiesje M. van der Flier, Wiesje M. van der Flier
Published 2017-05-01

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage

by Simon-Shlomo ePoil, Willem eDe Haan, Willem eDe Haan, Wiesje M van der Flier, Wiesje M van der Flier, Huibert D. Mansvelder, Philip eScheltens, Klaus eLinkenkaer-Hansen
Published 2013-10-01

Slowing of hippocampal activity correlates with cognitive decline in early-onset Alzheimer’s disease. An MEG study with virtual electrodes.

by Marjolein M.A. Engels, Arjan eHillebrand, Wiesje M Van Der Flier, Wiesje M Van Der Flier, Cornelis J Stam, Philip eScheltens, Elisabeth C.W. van Straaten, Elisabeth C.W. van Straaten
Published 2016-05-01

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

by Inger van Steenoven, Wiesje M. van der Flier, Philip Scheltens, Charlotte E. Teunissen, Afina W. Lemstra
Published 2019-10-01

Effect of long‐term storage in biobanks on cerebrospinal fluid biomarker Aβ1‐42, T‐tau, and P‐tau values

by Eline A.J. Willemse, Kees W.J. vanUffelen, Wiesje M. van derFlier, Charlotte E. Teunissen
Published 2017-01-01

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia

by Arianna Romani, Alessandro Trentini, Wiesje M. van der Flier, Tiziana Bellini, Giovanni Zuliani, Carlo Cervellati, Charlotte E. Teunissen
Published 2020-05-01

Exercise and Early-Onset Alzheimer’s Disease: Theoretical Considerations

by Astrid M. Hooghiemstra, Laura H.P. Eggermont, Philip Scheltens, Wiesje M. van der Flier, Erik J.A. Scherder
Published 2012-04-01

Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease

by Ellen Dicks, Lisa Vermunt, Wiesje M. van der Flier, Pieter Jelle Visser, Frederik Barkhof, Philip Scheltens, Betty M. Tijms
Published 2019-01-01

Microbleeds are associated with depressive symptoms in Alzheimer's disease

by Anna E. Leeuwis, Niels D. Prins, Astrid M. Hooghiemstra, Marije R. Benedictus, Philip Scheltens, Frederik Barkhof, Wiesje M. van derFlier
Published 2018-01-01

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

by Mara ten Kate, Frederik Barkhof, Pieter Jelle Visser, Charlotte E. Teunissen, Philip Scheltens, Wiesje M. van der Flier, Betty M. Tijms
Published 2017-09-01

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease

by Flora H. Duits, Gunnar Brinkmalm, Charlotte E. Teunissen, Ann Brinkmalm, Philip Scheltens, Wiesje M. Van der Flier, Henrik Zetterberg, Kaj Blennow
Published 2018-01-01

Cerebral Blood Flow and Cognitive Functioning in a Community-Based, Multi-Ethnic Cohort: The SABRE Study

by Anna E. Leeuwis, Lorna A. Smith, Andrew Melbourne, Alun D. Hughes, Alun D. Hughes, Marcus Richards, Niels D. Prins, Magdalena Sokolska, David Atkinson, Therese Tillin, Hans R. Jäger, Nish Chaturvedi, Nish Chaturvedi, Wiesje M. van der Flier, Wiesje M. van der Flier, Frederik Barkhof, Frederik Barkhof
Published 2018-09-01

Hypertensive Disorders of Pregnancy Appear Not to Be Associated with Alzheimer's Disease Later in Life

by Carolien N.H. Abheiden, Rebecca van Doornik, Annet M. Aukes, Wiesje M. van der Flier, Philip Scheltens, Christianne J.M. de Groot
Published 2015-09-01

Lumbar puncture in patients with neurologic conditions

by Rosha Babapour Mofrad, Femke H. Bouwman, Rosalinde E.R. Slot, Tessa Timmers, Wiesje M. van derFlier, Philip Scheltens, Charlotte E. Teunissen
Published 2017-01-01

Psychosocial Effects of Corona Measures on Patients With Dementia, Mild Cognitive Impairment and Subjective Cognitive Decline

by Ingrid S. van Maurik, Ingrid S. van Maurik, Els D. Bakker, Susanne van den Buuse, Freek Gillissen, Marleen van de Beek, Evelien Lemstra, Arenda Mank, Arenda Mank, Karlijn A. van den Bosch, Mardou van Leeuwenstijn, Femke H. Bouwman, Philip Scheltens, Wiesje M. van der Flier, Wiesje M. van der Flier
Published 2020-10-01

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease

by Rosha Babapour Mofrad, Niki S.M. Schoonenboom, Betty M. Tijms, Philip Scheltens, Pieter Jelle Visser, Wiesje M. van derFlier, Charlotte E. Teunissen
Published 2019-12-01

Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer’s disease

by Madhurima Chatterjee, Marta Del Campo, Tjado H. J. Morrema, Matthijs de Waal, Wiesje M. van der Flier, Jeroen J. M. Hoozemans, Charlotte E. Teunissen
Published 2018-06-01

Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review

by Arno de Wilde, Marieke M. van Buchem, René H. J. Otten, Femke Bouwman, Andrew Stephens, Frederik Barkhof, Philip Scheltens, Wiesje M. van der Flier
Published 2018-07-01

Single-subject grey matter graphs in Alzheimer's disease.

by Betty M Tijms, Christiane Möller, Hugo Vrenken, Alle Meije Wink, Willem de Haan, Wiesje M van der Flier, Cornelis J Stam, Philip Scheltens, Frederik Barkhof
Published 2013-01-01

Correction: Single-Subject Grey Matter Graphs in Alzheimer's Disease

by Betty M. Tijms, Christiane Möller, Hugo Vrenken, Alle Meije Wink, Willem de Haan, Wiesje M. van der Flier, Cornelis J. Stam, Philip Scheltens, Frederik Barkhof
Published 2013-01-01